A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Weill Medical College of Cornell University
Dana-Farber Cancer Institute
City of Hope Medical Center
Cedars-Sinai Medical Center
City of Hope Medical Center
Columbia University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
West Virginia University
Alliance for Clinical Trials in Oncology
Medical College of Wisconsin
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
University of Wisconsin, Madison
Medical College of Wisconsin
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
University of Texas Southwestern Medical Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
University of Pittsburgh
University of Texas Southwestern Medical Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Columbia University
Columbia University
Massachusetts General Hospital
University of Illinois at Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
New York Medical College
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
St. Petersburg State Pavlov Medical University